Persistent subclinical hypothyroidism is linked to severe cardiovascular disease; monitoring thyroid levels may aid in identifying patients at risk.
Researchers assessed whether a CAC score of 0 could decrease the risk for obstructive coronary artery disease among different age groups.
Researchers at TCT 2021 presented a new method for crossing wire-impenetrable proximal caps during chronic total occlusion percutaneous coronary intervention.
Researchers sought to determine the age at which young adults should be screened for coronary artery calcium to identify risk for premature atherosclerosis.
This meta-analysis examined the burden of subclinical CV disease in people living with HIV.
Ticagrelor monotherapy more effectively reduced risk for bleeding events following PCI among patients with CKD but had little effect on ischemic events.
Net recurrent cardiovascular events were not prevented by an initial invasive treatment strategy in the ISCHEMIA trial.
9.2 percent of those with zero CAC and intermediate 10-year atherosclerotic CVD risk had CCTA-verified atherosclerosis.
Personalized antiplatelet therapy using platelet function testing can decrease ischemic events in stable CAD.
A meta-analysis did not demonstrate a benefit of beta-blockers in reducing major adverse cardiovascular events in a population of patients with stable coronary artery disease without previous history of myocardial infarction or left ventricular dysfunction.